EPIXCHANGE's objectives will be achieved by the creation of a strategic partnership including two recognized academic institutions (P1 UniFE and P2 ULund), and a SME (P3 NsGene) developing ECB based therapeutic products.

EPIXCHANGE Consortium - Read More…


EPIXCHANGE aims at exploring, providing the basis for clinical application and implementing in the industrial arena new and unconventional strategies for the therapy of partial epilepsy advancing the state-of-the-art in the field.

Objectives - Read More…

Expected results & impact

The EPIXCHANGE project will help in developing and validating new strategies to approach specific, and yet unresolved, aspects of epilepsy: prevention and treatment of pharmacoresistant patients.

Expected results & impact - Read More…